Aggregator
Enabling evolvability to evolve
Science, Volume 387, Issue 6736, Page 825-826, February 2025.
An innate drive to save a life
Science, Volume 387, Issue 6736, Page 827-828, February 2025.
In Other Journals
Science, Volume 387, Issue 6736, Page 838-839, February 2025.
Comic relief
Science, Volume 387, Issue 6736, Page 902-902, February 2025.
Material-like robotic collectives with spatiotemporal control of strength and shape
Science, Volume 387, Issue 6736, Page 880-885, February 2025.
Interfacial bonding enhances thermoelectric cooling in 3D-printed materials
Science, Volume 387, Issue 6736, Page 845-850, February 2025.
Nickel promotes selective ethylene epoxidation on silver
Science, Volume 387, Issue 6736, Page 869-873, February 2025.
Spiro-C(sp3)-atom transfer: Creating rigid three-dimensional structures with Ph2SCN2
Science, Volume 387, Issue 6736, Page 885-892, February 2025.
Visible light–triggered depolymerization of commercial polymethacrylates
Science, Volume 387, Issue 6736, Page 874-880, February 2025.
Neuronal FAM171A2 mediates α-synuclein fibril uptake and drives Parkinson’s disease
Science, Volume 387, Issue 6736, Page 892-900, February 2025.
Magnetic modulation of keyhole instability during laser welding and additive manufacturing
Science, Volume 387, Issue 6736, Page 864-869, February 2025.
Morality in a more-than-human world
Science, Volume 387, Issue 6736, Page 833-833, February 2025.
The perils of labor
Science, Volume 387, Issue 6736, Page 832-832, February 2025.
News at a glance: RFK Jr. sworn in, more R1 universities, and besieged peatlands
The latest in science and policy
What’s tinyML? The Global South’s alternative to power-hungry, pricey AI
Stamp-size devices running machine learning models are tackling agricultural, health, and conservation problems in resource-poor regions
Financial peril could doom a famed New York paleontological institute
“Exceptional” fossil collections housed by the Paleontological Research Institute risk being orphaned
There’s a big courtroom showdown over NIH’s ‘indirect costs’ this week. What are they?
Here’s the story behind the billions in payments to institutions with research grants that NIH wants to cut
Unscrambling the cellular and molecular threads of Neuroplasticity: Insights into Alzheimer's disease pathogenesis
Alzheimer's disease (AD) is predominantly the most recurring and devastating neurological condition among the elderly population, characterized by the accumulation of amyloid-β (Aβ) and phosphorylated tau proteins, and is accompanied by progressive decline of learning and memory. Due to its complex and multifactorial etiology, a wide variety of therapeutic interventions have been developed. Despite constant advancements in the field, effective treatments that ameliorate the severity of...
Drug repurposing for Alzheimer's disease and other neurodegenerative disorders
Repurposed drugs provide a rich source of potential therapies for Alzheimer's disease (AD) and other neurodegenerative disorders (NDD). Repurposed drugs have information from non-clinical studies, phase 1 dosing, and safety and tolerability data collected with the original indication. Computational approaches, "omic" studies, drug databases, and electronic medical records help identify candidate therapies. Generic repurposed agents lack intellectual property protection and are rarely advanced to...
Unscrambling the cellular and molecular threads of Neuroplasticity: Insights into Alzheimer's disease pathogenesis
Alzheimer's disease (AD) is predominantly the most recurring and devastating neurological condition among the elderly population, characterized by the accumulation of amyloid-β (Aβ) and phosphorylated tau proteins, and is accompanied by progressive decline of learning and memory. Due to its complex and multifactorial etiology, a wide variety of therapeutic interventions have been developed. Despite constant advancements in the field, effective treatments that ameliorate the severity of...